Clincosm LogoSign in Get a demo

Melanoma

Showing NaN - NaN of 119
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

Melanoma, Unresectable Melanoma Trial in Los Angeles, Boston, New York (Sarilumab, Ipilimumab Injection, Nivolumab/Relatlimab)

Not yet recruiting
  • Melanoma
  • Unresectable Melanoma
  • Los Angeles, California
  • +3 more
Aug 4, 2022

Melanoma Trial in United States (CMP-001, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • Phoenix, Arizona
  • +12 more
Aug 1, 2022

Melanoma, Advanced Melanoma, Metastatic Melanoma Trial in United States (CMP-001, Nivolumab)

Active, not recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +24 more
Aug 1, 2022

Melanoma, Non-small Sell Lung Cancer (NSCLC), Triple Negative Breast Cancer Trial in Worldwide (PDR001)

Completed
Has Results
  • Melanoma
  • +4 more
  • PDR001
  • Baltimore, Maryland
  • +40 more
Aug 2, 2022

Melanoma Trial in Worldwide (Encorafenib, Binimetinib, Pembrolizumab)

Recruiting
  • Melanoma
  • Tucson, Arizona
  • +112 more
Jul 26, 2022

Melanoma, NSCLC, Squamous Cell Carcinoma of Head and Neck Trial in United States (GEN-011, IL-2, Fludarabine)

Terminated
  • Melanoma
  • +8 more
  • GEN-011
  • +3 more
  • Gilbert, Arizona
  • +7 more
Jul 13, 2022

Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (Combination of NKTR-214 + nivolumab)

Completed
  • Melanoma
  • +6 more
  • Combination of NKTR-214 + nivolumab
  • La Jolla, California
  • +57 more
Jun 22, 2022

Melanoma Trial in Boston, Harrison, New York (Dabrafenib, Trametinib, Phenformin)

Active, not recruiting
  • Melanoma
  • Boston, Massachusetts
  • +2 more
Jun 14, 2022

Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial in United States (DCC-3116, Trametinib, Binimetinib)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +5 more
  • Boston, Massachusetts
  • +4 more
May 25, 2022

Unresectable And Metastatic Melanoma: The Optimize Study

Completed
  • Melanoma
    • Muscle Shoals, Alabama
    • +65 more
    May 17, 2022

    Melanoma, Non Small Cell Lung Cancer Trial in United States (VV1, Cemiplimab, Ipilumumab)

    Recruiting
    • Melanoma
    • Non Small Cell Lung Cancer
    • VV1
    • +2 more
    • Phoenix, Arizona
    • +22 more
    Apr 21, 2022

    Melanoma Trial in Los Angeles, Boston, New York (Ipilimumab, Nivolumab, Tocilizumab)

    Recruiting
    • Melanoma
    • Los Angeles, California
    • +3 more
    Mar 29, 2022

    NSCLC, Small Cell Lung Cancer, Urothelial Carcinoma Trial in United States (N-803 + Pembrolizumab, N-803 + Nivolumab, N-803 +

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • +12 more
    • N-803 + Pembrolizumab
    • +9 more
    • Anchorage, Alaska
    • +34 more
    Apr 4, 2022

    Colorectal Cancer (CRC), Endometrial Cancer, Melanoma Trial in United States (Pembrolizumab, itacitinib, INCB050465)

    Completed
    • Colorectal Cancer (CRC)
    • +10 more
    • San Francisco, California
    • +16 more
    Mar 30, 2022

    Melanoma Trial in Worldwide (Relatlimab, Nivolumab)

    Active, not recruiting
    Has Results
    • Melanoma
    • Relatlimab
    • Nivolumab
    • Tucson, Arizona
    • +126 more
    Mar 2, 2022

    Cancer, Solid Tumor, Melanoma Trial in United States (ST-067)

    Recruiting
    • Cancer
    • +7 more
    • ST-067
    • Scottsdale, Arizona
    • +3 more
    Mar 21, 2022

    Plasma Genotyping asNoninvasive Biomarker for Genotype-directed

    Recruiting
    • NSCLC
    • Melanoma
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Mar 1, 2022

      Melanoma Trial in Boston (WDVAX)

      Active, not recruiting
      • Melanoma
      • WDVAX
      • Boston, Massachusetts
      • +1 more
      Feb 22, 2022

      Patterns for Immunotherapy Agents and BRAF/MEK Inhibitors Used

      Completed
      • Melanoma
      • Non-Interventional
      • Boston, Massachusetts
        Local Institution
      Jan 27, 2022

      Melanoma Trial in United States (MGA271)

      Terminated
      • Melanoma
      • MGA271
      • Los Angeles, California
      • +6 more
      Feb 4, 2022

      Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)

      Completed
      • Prostate Cancer
      • +6 more
      • MGA271
      • Los Angeles, California
      • +11 more
      Feb 4, 2022

      Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

      Terminated
      • Mesothelioma
      • +12 more
      • MGD009
      • Los Angeles, California
      • +19 more
      Feb 4, 2022

      Melanoma Trial in Boston (Autologous, lethally irradiated melanoma cells)

      Active, not recruiting
      • Melanoma
      • Autologous, lethally irradiated melanoma cells
      • Boston, Massachusetts
      • +1 more
      Feb 2, 2022